Chapter 1.BIOPHARMACEUTICAL MARKET     – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.BIOPHARMACEUTICAL MARKET     – Executive Summary

2.1. Market Size & Forecast – (2022 – 2026) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-16 Impact Analysis

      2.3.1. Impact during 2022 - 2026

      2.3.2. Impact on Supply – Demand

Chapter 3.BIOPHARMACEUTICAL MARKET     – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.BIOPHARMACEUTICAL MARKET     - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. BIOPHARMACEUTICAL MARKET    - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.BIOPHARMACEUTICAL MARKET     – By Product:

6.1. Monoclonal Antibodies

6.2. Recombinant Growth Factors

6.3. Purified Proteins

6.4. Recombinant Proteins

6.5. Recombinant Hormones

6.6. Vaccines

6.7. Recombinant Enzymes

6.8. Cell and Gene therapies

6.9. Synthetic Immunomodulators

6.10. Other Product types

Chapter 7.BIOPHARMACEUTICAL MARKET    – By Therapeutic Application

7.1.Oncology

7.2. Inflammatory and Infectious diseases

7.3. Autoimmune Disorders

7.4. Metabolic Disorders

7.5. Hormonal Disorders

7.6. Cardiovascular Diseases

7.7. Neurological Diseases

7.8. Other Diseases

Chapter 8.BIOPHARMACEUTICAL MARKET    – By Region

8.1. North America

8.2. Europe

8.3. The Asia Pacific

8.4. Latin America

8.5. The Middle East

8.6. Africa